Fluorescein with lidocaine
Brand names: Minims lidocaine and fluorescein
This is a combined topical ophthalmic diagnostic preparation pairing fluorescein, an orange dye, with the local anaesthetic lidocaine, used to facilitate examination such as applanation tonometry, foreign body removal and assessment of corneal epithelial integrity.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Fluorescein stains areas of de-epithelialised cornea and conjunctiva and fluoresces under blue light to reveal epithelial defects, while lidocaine produces rapid surface anaesthesia by blocking neuronal sodium channels.
Prescribing in practice
- This is for diagnostic use only and must never be supplied for repeated self-administration, as continued topical anaesthesia causes corneal epithelial toxicity, delayed healing and ulceration.
- The anaesthetised eye loses its protective blink and corneal sensation, so it should be shielded from injury until sensation returns.
- Fluorescein can permanently stain soft contact lenses, which should be removed beforehand.
Monitoring
No laboratory monitoring is required; the clinician observes the staining pattern under cobalt-blue light and confirms adequate but transient anaesthesia during the procedure.
Counselling the patient
- Your eye will be numb for a short while, so avoid rubbing or touching it until normal feeling returns.
- The dye may briefly tint your tears yellow-orange.
- Leave contact lenses out until advised it is safe to reinsert them.
Evidence & guidelines
Combined fluorescein and local anaesthetic drops are standard adjuncts for tonometry and minor ocular procedures in routine ophthalmic and emergency practice.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- ASA Physical Status Classification · Pre-operative Risk
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- Framingham Heart Failure Diagnostic Criteria · Heart Failure
- ADAPT Protocol for Cardiac Event Risk · Chest Pain
- Pericarditis Diagnostic Score (Imazio Criteria) · Pericardial Disease
- Brugada Syndrome Diagnostic Criteria · Channelopathy / Sudden Cardiac Death
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme